A Multi-center, Single-arm Study of the TAXUS Liberte-SR Stent for the Direct Stenting Treatment of Patients With de Novo Coronary Artery Lesions.

Trial Profile

A Multi-center, Single-arm Study of the TAXUS Liberte-SR Stent for the Direct Stenting Treatment of Patients With de Novo Coronary Artery Lesions.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Feb 2012

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
  • Focus Registrational; Therapeutic Use
  • Acronyms ATLAS-DS
  • Sponsors Boston Scientific Corporation
  • Most Recent Events

    • 01 Feb 2012 Additional lead trial investigator (Peter Maurer) identified and added as reported by ClinicalTrials.gov.
    • 29 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Apr 2011 Actual end date is Sep 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top